Abstract:BACKGROUND:A great quantity of cell loss in early stage following stem cell transplantation can significantly affect transplantation effect.Presently,it is confirmed that overexpression of AKT1 gene significantly inhibit cell apoptosis.OBJECTIVE:To explore whether AKT1 gene overexpression can block stem cell apoptosis under hypoxic condition following pig autologous bone marrow mesenchymal stem cell (BMSC) transplantation,and the effect of repairing damaged myocardium.DESIGN,TIME AND SETTING:The randomized controlled animal study was performed at the Soochow University from August 2005 to February 2007.MATERIALS:A total of 24 healthy male Meishan pigs were supplied by the Animal Experimental Center of Soochow University.METHODS:The CDS (regulation domin of AKT1) AKT1-cDNA fragment was amplified.Lentivector Packaging Kit was used to transfect BMSCs after synthesized with pCDH1-AKT1 shuttling plasmid.Following BrdU labeling,models of myocardial infarction were constructed by occluding the distal left anterior descending coronary artery in pigs with gelatin sponge.4 weeks later,pigs were randomly divided into four groups:the model control group,the DMEM group,the BMSCs group,and the AKT-transfected group.In model control group,there was no other injection after occluding the left anterior descending coronary artery.In the DMEM group,5 mL DMEM was injected into the coronary artery.5 mL BMSCs (1×107 cells) were infused into the coronary artery in the BMSCs group.5 mL BMSCs transfected with the AKT1 gene were injected in the AKT-transfected group MAIN OUTCOME MEASURES:Western blot analysis and real time RT-PCR were used to test the plasmid.The cardiac function was evaluated by magnetic resonance image.Histological characteristics of the myocardium were observed using immunohistochemistry.Serum vascular endothelial growth factor and transforming growth factor β1 levels were determined by ELISA.RESULTS:AKT1-cDNA was cloned into pCDH1-MCS1-EF1-copGFP and the sequence was confirmed in comparison with the published one.AKT mRNA expression could be detected distinctly 24 and 48 hours after transfecting cells.The expression of AKT1 intensity in MSCs remained strong 2 weeks later with detected by real time RT-PCR and Western blot analysis.AKT1-mRNA transcriptional levels were 120 times of primary cells.Before the cell implantation,the left ventricular end-diastolic dimension increased and the stroke volume decreased in the myocardial infarction hearts.The cardiac function was significantly improved after cell implantation,and the implanted MSCs prevented the infarct region from thinning and expanding,improved contraction and increased perfusion in all groups relative to the control hearts.The left ventricular chamber size was smaller in the hearts with being transplanted cells than that in the control hearts.Moreover,the improvement was even markedly greater in AKT-transfected group (P < 0.05).Hematoxylin-eosin staining results showed that fibering was significant in the model control group and DMEM group.Island-like myocardium was observed in the infarct zone of the BMSCs group and AKT-transfected group,and plenty of small vessels-shape structure was detected in the AKT-transfected group.Immunohistochemistry demonstrated that Von Willebrand Factor (vWF) and Cx-43 expression was determined in the myocardium in the BMSCs group and AKT-transfected group,and the proportion of BrdU and Cx-43-positive cells to BrdU-positive cells was significantly greater in the AKT-transfected group compared with the BMSCs group 4 weeks following transplantation (P < 0.05).Following cell transplantation,vascular endothelial growth factor levels were gradually increased,peaked at 1 week,gradually decreased,and reached a normal level at 4 weeks.Transforming growth factor β1 levels were gradually reduced,and significantly less than the model control group,DMEM group 4 weeks later (P < 0.05),and significantly lower than that pretransplantation (P < 0.05).CONCLUSION:Using lentiviral vector to construct with AKT1 gene could stably make BMSCs overexpress AKT1.The BMSCs engraftment in host myocardium might improve the left ventricle function by attenuating the contractile dysfunction and pathologic thinning in this model of left ventricular wall infarction.AKT1 overexpression can significantly improve cardiac function following infarction.

HGF Percutaneous Endocardial Injection Induces Cardiomyocyte Proliferation and Rescues Cardiac Function in Pigs

VEGF 165 and HGF Improving Cardiomyocyte Proliferation in Experimental Porcine After Myocardial Infarction

Induction of Collateral Artery Growth and Improvement of Post-Infarct Heart Function by Hepatocyte Growth Factor Gene Transfer

Treatment of chronical myocardial ischemia by adenovirus-mediated hepatocyte growth factor gene transfer in minipigs

Improvement of Heart Function in Postinfarct Heart Failure Swine Models after Hepatocyte Growth Factor Gene Transfer: Comparison of Low-, Medium- and High-Dose Groups

Recruitment of Stem Cells by Hepatocyte Growth Factor Via Intracoronary Gene Transfection in the Postinfarction Heart Failure

Gene Therapy with Hepatocyte Growth Factor Improves Left Ventricular Systolic Function After Myocardial Infarction: A Systematic Review and Meta-analysis of Pig Models

Coexpression Of Vegf And Angiopoietin-1 Promotes Angiogenesis And Cardiomyocyte Proliferation Reduces Apoptosis In Porcine Myocardial Infarction (Mi) Heart

Alginate sulfate-nanoparticles loaded with hepatocyte growth factor and insulin-like growth factor-1 improve left ventricular repair in a porcine model of myocardial ischemia reperfusion injury

Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.

Significant Improvement of Heart Function by Cotransplantation of Human Mesenchymal Stem Cells and Fetal Cardiomyocytes in Postinfarcted Pigs.

Transplantation of Angiogenin-Overexpressing Mesenchymal Stem Cells Synergistically Augments Cardiac Function in A Porcine Model of Chronic Ischemia

Comparative Study of Effects of Bone Marrow Cell Vs. Ad5-HGF Administration Via Non-Infarct-related Artery Injection in Myocardial Infarction in Swine

Long-term Efficacy of Transendocardial Injection of Vascular Endothelial Growth Factor into Ischemic Porcine Myocardium

Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine

Transplantation of autologous bone marrow mesenchymal stem cells modified with AKT1 for treating pig ischemic cardiomyopathy

Adenoviral VEGF-DΔN ΔC gene therapy for myocardial ischemia

Effects of Hepatocyte Growth Factor Overexpressed Bone Marrow‐derived Mesenchymal Stem Cells on Prevention from Left Ventricular Remodelling and Functional Improvement in Infarcted Rat Hearts

[Intracoronary and Hypodermic Injection of Granulocyte Colony-Stimulating Factor Improved Cardiac Function in Swine with Chronic Myocardial Ischemia].

Cardiac-specific expression of the hepatocyte growth factor (HGF) under the control of a TnIc promoter confers a heart protective effect after myocardial infarction (MI).

Intracoronary Administration of Microencapsulated HGF in a Reperfused Myocardial Infarction Swine Model